# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-17-023120
Filing Date
2017-04-28
Accepted
2017-04-28 14:45:44
Documents
7
Period of Report
2017-06-07
Effectiveness Date
2017-04-28

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | v465343_def14a.htm | DEF 14A | 318745
2 | GRAPHIC | line.gif | GRAPHIC | 43
3 | GRAPHIC | logo_mustangbio.jpg | GRAPHIC | 62056
4 | GRAPHIC | sig_robyn.jpg | GRAPHIC | 9830
5 | GRAPHIC | spacer.gif | GRAPHIC | 43
6 | GRAPHIC | v465343_proxy-1.jpg | GRAPHIC | 988605
7 | GRAPHIC | v465343_proxy-2.jpg | GRAPHIC | 458183
| Complete submission text file | 0001144204-17-023120.txt |  | 2411671

Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 7816524507
MUSTANG BIO, INC. (Filer) CIK: 0001680048 (see all company filings)

EIN.: 473828760 | State of Incorp.: DE | Fiscal Year End: 0312
Type: DEF 14A | Act: 34 | File No.: 000-55668 | Film No.: 17794511
SIC: 2834 Pharmaceutical Preparations